Citigroup Maintains Sell on Integra Lifesciences, Lowers Price Target to $11

Benzinga · 10/31 20:18
Citigroup analyst Joanne Wuensch maintains Integra Lifesciences (NASDAQ:IART) with a Sell and lowers the price target from $12 to $11.